Skip to main navigation Skip to search Skip to main content

Interleukin-17 inhibitors in myasthenia gravis: really bad or maybe good?

  • Keimyung University

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)2981-2982
Number of pages2
JournalNeurological Sciences
Volume44
Issue number8
DOIs
StatePublished - Aug 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this